164 related articles for article (PubMed ID: 17894009)
1. Catastrophic antiphospholipid syndrome: lessons from the "CAPS Registry"--a tribute to the late Josep Font.
Cervera R; Bucciarelli S; Espinosa G; Gómez-Puerta JA; Ramos-Casals M; Shoenfeld Y; Piette JC; Asherson RA
Ann N Y Acad Sci; 2007 Jun; 1108():448-56. PubMed ID: 17894009
[TBL] [Abstract][Full Text] [Related]
2. Lessons from the catastrophic antiphospholipid syndrome (CAPS) registry.
Cervera R; Espinosa G; Bucciarelli S; Gómez-Puerta JA; Font J
Autoimmun Rev; 2006 Dec; 6(2):81-4. PubMed ID: 17138248
[TBL] [Abstract][Full Text] [Related]
3. The CAPS Registry: morbidity and mortality of the catastrophic antiphospholipid syndrome.
Bucciarelli S; Espinosa G; Cervera R
Lupus; 2009 Sep; 18(10):905-12. PubMed ID: 19671791
[TBL] [Abstract][Full Text] [Related]
4. Catastrophic antiphospholipid syndrome (CAPS): update from the 'CAPS Registry'.
Cervera R;
Lupus; 2010 Apr; 19(4):412-8. PubMed ID: 20353979
[TBL] [Abstract][Full Text] [Related]
5. Update on the catastrophic antiphospholipid syndrome and the "CAPS Registry".
Cervera R; Espinosa G
Semin Thromb Hemost; 2012 Jun; 38(4):333-8. PubMed ID: 22618528
[TBL] [Abstract][Full Text] [Related]
6. CAPS Registry.
Cervera R
Lupus; 2012 Jun; 21(7):755-7. PubMed ID: 22635223
[TBL] [Abstract][Full Text] [Related]
7. Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the "CAPS Registry".
Cervera R; Bucciarelli S; Plasín MA; Gómez-Puerta JA; Plaza J; Pons-Estel G; Shoenfeld Y; Ingelmo M; Espinos G;
J Autoimmun; 2009; 32(3-4):240-5. PubMed ID: 19324520
[TBL] [Abstract][Full Text] [Related]
8. Disseminated intravascular coagulation in catastrophic antiphospholipid syndrome: clinical and haematological characteristics of 23 patients.
Asherson RA; Espinosa G; Cervera R; Gómez-Puerta JA; Musuruana J; Bucciarelli S; Ramos-Casals M; Martínez-González AL; Ingelmo M; Reverter JC; Font J; Triplett DA
Ann Rheum Dis; 2005 Jun; 64(6):943-6. PubMed ID: 15897312
[TBL] [Abstract][Full Text] [Related]
9. The acute respiratory distress syndrome in catastrophic antiphospholipid syndrome: analysis of a series of 47 patients.
Bucciarelli S; Espinosa G; Asherson RA; Cervera R; Claver G; Gómez-Puerta JA; Ramos-Casals M; Ingelmo M;
Ann Rheum Dis; 2006 Jan; 65(1):81-6. PubMed ID: 15919677
[TBL] [Abstract][Full Text] [Related]
10. Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors.
Bucciarelli S; Cervera R; Espinosa G; Gómez-Puerta JA; Ramos-Casals M; Font J
Autoimmun Rev; 2006 Dec; 6(2):72-5. PubMed ID: 17138246
[TBL] [Abstract][Full Text] [Related]
11. The catastrophic antiphospholipid syndrome in Serbia: diagnostic and management problems.
Stojanovich L
Clin Rev Allergy Immunol; 2009 Jun; 36(2-3):98-103. PubMed ID: 19048415
[TBL] [Abstract][Full Text] [Related]
12. Rituximab use in the catastrophic antiphospholipid syndrome: descriptive analysis of the CAPS registry patients receiving rituximab.
Berman H; Rodríguez-Pintó I; Cervera R; Morel N; Costedoat-Chalumeau N; Erkan D; Shoenfeld Y; Espinosa G;
Autoimmun Rev; 2013 Sep; 12(11):1085-90. PubMed ID: 23777822
[TBL] [Abstract][Full Text] [Related]
13. Clinical and laboratory features of the catastrophic antiphospholipid syndrome.
Stojanovich L; Marisavljevic D; Rovensky J; Djokovich A; Kozáková D; Milinic N
Clin Rev Allergy Immunol; 2009 Jun; 36(2-3):74-9. PubMed ID: 19052923
[TBL] [Abstract][Full Text] [Related]
14. Pediatric catastrophic antiphospholipid syndrome: descriptive analysis of 45 patients from the "CAPS Registry".
Berman H; Rodríguez-Pintó I; Cervera R; Gregory S; de Meis E; Rodrigues CE; Aikawa NE; de Carvalho JF; Springer J; Niedzwiecki M; Espinosa G;
Autoimmun Rev; 2014 Feb; 13(2):157-62. PubMed ID: 24145009
[TBL] [Abstract][Full Text] [Related]
15. Ferritin in the antiphospholipid syndrome and its catastrophic variant (cAPS).
Agmon-Levin N; Rosário C; Katz BS; Zandman-Goddard G; Meroni P; Cervera R; Stojanovich L; Blank M; Pierangeli S; Praprotnik S; Meis Ed; Seguro LP; Ruffatti A; Pengo V; Tincani A; Doria A; Shoenfeld Y
Lupus; 2013 Nov; 22(13):1327-35. PubMed ID: 24036580
[TBL] [Abstract][Full Text] [Related]
16. [Case series and clinical analysis of 14 cases of catastrophic antiphospholipid syndrome].
Gu JY; Lu C; Shi H; Yang CD
Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 50(6):1033-1038. PubMed ID: 30562777
[TBL] [Abstract][Full Text] [Related]
17. Eculizumab use in catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis from the "CAPS Registry".
López-Benjume B; Rodríguez-Pintó I; Amigo MC; Erkan D; Shoenfeld Y; Cervera R; Espinosa G;
Autoimmun Rev; 2022 Apr; 21(4):103055. PubMed ID: 35085802
[TBL] [Abstract][Full Text] [Related]
18. Multiorgan failure and antiphospholipid antibodies: the catastrophic antiphospholipid (Asherson's) syndrome.
Asherson RA
Immunobiology; 2005; 210(10):727-33. PubMed ID: 16325490
[TBL] [Abstract][Full Text] [Related]
19. Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome.
Cervera R; Font J; Gómez-Puerta JA; Espinosa G; Cucho M; Bucciarelli S; Ramos-Casals M; Ingelmo M; Piette JC; Shoenfeld Y; Asherson RA;
Ann Rheum Dis; 2005 Aug; 64(8):1205-9. PubMed ID: 15708888
[TBL] [Abstract][Full Text] [Related]
20. Catastrophic antiphospholipid syndrome (CAPS).
Sciascia S; Lopez-Pedrera C; Roccatello D; Cuadrado MJ
Best Pract Res Clin Rheumatol; 2012 Aug; 26(4):535-41. PubMed ID: 23040365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
